X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs SANOFI INDIA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA SANOFI INDIA FULFORD INDIA/
SANOFI INDIA
 
P/E (TTM) x 398.8 32.9 1,212.8% View Chart
P/BV x 6.2 6.3 99.2% View Chart
Dividend Yield % 0.1 1.4 5.9%  

Financials

 FULFORD INDIA   SANOFI INDIA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
SANOFI INDIA
Dec-16
FULFORD INDIA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs9424,560 20.7%   
Low Rs4504,400 10.2%   
Sales per share (Unadj.) Rs691.41,028.5 67.2%  
Earnings per share (Unadj.) Rs11.5129.0 8.9%  
Cash flow per share (Unadj.) Rs15.4186.0 8.3%  
Dividends per share (Unadj.) Rs2.0068.00 2.9%  
Dividend yield (eoy) %0.31.5 18.9%  
Book value per share (Unadj.) Rs380.0753.6 50.4%  
Shares outstanding (eoy) m3.9023.03 16.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.4 23.1%   
Avg P/E ratio x60.734.7 174.8%  
P/CF ratio (eoy) x45.324.1 188.1%  
Price / Book Value ratio x1.85.9 30.8%  
Dividend payout %17.452.7 33.1%   
Avg Mkt Cap Rs m2,714103,174 2.6%   
No. of employees `0000.43.6 12.3%   
Total wages/salary Rs m5053,592 14.1%   
Avg. sales/employee Rs Th6,073.06,537.7 92.9%   
Avg. wages/employee Rs Th1,137.4991.4 114.7%   
Avg. net profit/employee Rs Th100.7819.8 12.3%   
INCOME DATA
Net Sales Rs m2,69623,686 11.4%  
Other income Rs m125708 17.7%   
Total revenues Rs m2,82224,394 11.6%   
Gross profit Rs m-465,281 -0.9%  
Depreciation Rs m151,313 1.2%   
Interest Rs m1015 63.3%   
Profit before tax Rs m544,661 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,691 0.6%   
Profit after tax Rs m452,970 1.5%  
Gross profit margin %-1.722.3 -7.7%  
Effective tax rate %17.736.3 48.7%   
Net profit margin %1.712.5 13.2%  
BALANCE SHEET DATA
Current assets Rs m1,73815,673 11.1%   
Current liabilities Rs m5456,678 8.2%   
Net working cap to sales %44.338.0 116.6%  
Current ratio x3.22.3 136.0%  
Inventory Days Days4876 63.8%  
Debtors Days Days422 19.3%  
Net fixed assets Rs m128,098 0.1%   
Share capital Rs m39230 16.9%   
"Free" reserves Rs m1,44317,088 8.4%   
Net worth Rs m1,48217,356 8.5%   
Long term debt Rs m00-   
Total assets Rs m2,07725,400 8.2%  
Interest coverage x6.7311.7 2.2%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.9 139.2%   
Return on assets %2.611.8 22.2%  
Return on equity %3.017.1 17.6%  
Return on capital %4.326.9 16.0%  
Exports to sales %024.5 0.0%   
Imports to sales %24.528.0 87.4%   
Exports (fob) Rs mNA5,801 0.0%   
Imports (cif) Rs m6596,627 9.9%   
Fx inflow Rs m177,145 0.2%   
Fx outflow Rs m6736,846 9.8%   
Net fx Rs m-656299 -219.4%   
CASH FLOW
From Operations Rs m903,226 2.8%  
From Investments Rs m105-1,555 -6.7%  
From Financial Activity Rs m-14-1,818 0.8%  
Net Cashflow Rs m181-147 -122.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 60.4 124.2%  
Indian inst/Mut Fund % 3.8 14.4 26.4%  
FIIs % 0.1 14.6 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.5 201.9%  
Shareholders   4,783 15,184 31.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Power Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS